Variant report

Variant	rs12340861
Chromosome Location	chr9:117159223-117159224
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr9:117159163-117159534	IMR90	lung:	n/a	n/a
2	MAX	chr9:117159125-117160977	K562	blood:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
3	ATF3	chr9:117159187-117159531	K562	blood:	n/a	n/a
4	MYC	chr9:117159174-117159846	K562	blood:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
5	CEBPB	chr9:117159011-117159665	HCT-116	colon:	n/a	n/a
6	EP300	chr9:117159066-117160688	K562	blood:	n/a	chr9:117160202-117160218 chr9:117159332-117159346 chr9:117160148-117160162
7	CEBPB	chr9:117159162-117159548	HepG2	liver:	n/a	n/a
8	MAX	chr9:117159219-117159522	K562	blood:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
9	PML	chr9:117159114-117159604	K562	blood:	n/a	n/a
10	CEBPB	chr9:117159106-117159515	K562	blood:	n/a	n/a
11	MAX	chr9:117159181-117159950	HepG2	liver:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
12	CEBPB	chr9:117159001-117159718	HCT-116	colon:	n/a	n/a
13	POLR2A	chr9:117158911-117160859	K562	blood:	n/a	n/a
14	UBTF	chr9:117159161-117159494	K562	blood:	n/a	n/a
15	MAX	chr9:117159160-117159829	K562	blood:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
16	POLR2A	chr9:117159091-117161169	K562	blood:	n/a	n/a
17	CEBPB	chr9:117159186-117159437	K562	blood:	n/a	n/a
18	CEBPB	chr9:117159167-117159521	H1-hESC	embryonic stem cell:	n/a	n/a
19	TBL1XR1	chr9:117159170-117161120	K562	blood:	n/a	n/a
20	POLR2A	chr9:117159221-117159320	GM12878	blood:	n/a	n/a
21	EP300	chr9:117159130-117159479	HepG2	liver:	n/a	chr9:117159332-117159346
22	RCOR1	chr9:117159062-117161188	K562	blood:	n/a	n/a
23	MAZ	chr9:117159115-117161156	K562	blood:	n/a	chr9:117159335-117159344 chr9:117159413-117159422
24	TEAD4	chr9:117159139-117159732	K562	blood:	n/a	n/a
25	TRIM28	chr9:117159139-117159648	K562	blood:	n/a	chr9:117159609-117159617
26	HCFC1	chr9:117159115-117159693	K562	blood:	n/a	n/a
27	POLR2A	chr9:117159093-117161156	HepG2	liver:	n/a	n/a
28	CEBPB	chr9:117159175-117159521	Hela-S3	cervix:	n/a	n/a
29	HEY1	chr9:117159114-117159461	HepG2	liver:	n/a	n/a
30	JUN	chr9:117158072-117161273	K562	blood:	n/a	chr9:117160789-117160798
31	POLR2A	chr9:117159130-117159598	HCT-116	colon:	n/a	n/a
32	EP300	chr9:117159214-117159432	Hela-S3	cervix:	n/a	chr9:117159332-117159346
33	BHLHE40	chr9:117159147-117159508	K562	blood:	n/a	n/a
34	CEBPB	chr9:117159218-117159508	A549	lung:	n/a	n/a
35	POLR2A	chr9:117158969-117159520	GM12878	blood:	n/a	n/a
36	MYC	chr9:117159211-117159568	K562	blood:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
37	POLR2A	chr9:117158930-117159426	GM12878	blood:	n/a	n/a
38	POLR2A	chr9:117159143-117161180	GM18505	blood:	n/a	n/a
39	CUX1	chr9:117159172-117159318	K562	blood:	n/a	n/a
40	JUND	chr9:117159005-117161224	K562	blood:	n/a	chr9:117160789-117160798
41	CEBPB	chr9:117159160-117159551	K562	blood:	n/a	n/a
42	ZNF143	chr9:117159046-117160967	K562	blood:	n/a	chr9:117160785-117160803
43	MTA3	chr9:117159182-117160818	GM12878	blood:	n/a	n/a
44	E2F6	chr9:117159152-117160146	H1-hESC	embryonic stem cell:	n/a	n/a
45	MAZ	chr9:117159005-117161087	IMR90	lung:	n/a	chr9:117159335-117159344 chr9:117159413-117159422
46	POLR2A	chr9:117159191-117159632	GM12892	blood:	n/a	n/a
47	MXI1	chr9:117158969-117161216	IMR90	lung:	n/a	chr9:117160275-117160290 chr9:117159414-117159423
48	ZMIZ1	chr9:117159179-117160047	K562	blood:	n/a	n/a
49	POLR2A	chr9:117158970-117159479	GM12892	blood:	n/a	n/a
50	POLR2A	chr9:117159086-117160819	IMR90	lung:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:117157841..117159621-chr9:117357449..117360397,2	K562	blood:
2	chr9:117143764..117145416-chr9:117158182..117159722,2	MCF-7	breast:
3	chr9:117158501..117160733-chr9:117167774..117169910,2	K562	blood:
4	chr9:117158123..117160127-chr9:117266817..117268504,2	MCF-7	breast:
5	chr9:117108355..117112346-chr9:117155430..117161997,5	MCF-7	breast:
6	chr9:117157483..117160284-chr9:117162709..117165492,2	K562	blood:
7	chr9:117136553..117139395-chr9:117157861..117162089,3	K562	blood:
8	chr9:117155204..117158702-chr9:117159212..117161849,5	MCF-7	breast:
9	chr9:117158447..117160644-chr9:117174515..117176185,2	K562	blood:
10	chr9:117135087..117138049-chr9:117158281..117160655,2	MCF-7	breast:
11	chr9:117157540..117162429-chr9:117265948..117270229,5	K562	blood:
12	chr9:117158967..117160760-chr9:117784217..117787013,2	K562	blood:
13	chr9:117148465..117156866-chr9:117157996..117162015,11	K562	blood:

Variant related genes	Relation type
AKNA	TF binding region
ENSG00000095397	Chromatin interaction
ENSG00000106948	Chromatin interaction

Extended variants
information (count: 54 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:20)

rs_ID	r²[population]
rs10114489	0.95[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs1075559	0.93[JPT][hapmap];0.90[YRI][hapmap];0.93[AFR][1000 genomes];0.92[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs1075560	1.00[JPT][hapmap];0.85[YRI][hapmap];0.82[AFR][1000 genomes];0.89[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs10817601	0.85[CHB][hapmap];1.00[JPT][hapmap];0.85[YRI][hapmap];1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs10817603	1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs10817604	1.00[JPT][hapmap];0.85[YRI][hapmap];0.96[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs10817605	1.00[JPT][hapmap];0.85[YRI][hapmap];0.96[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs12340863	0.84[CEU][hapmap];0.85[CHB][hapmap];0.92[JPT][hapmap];0.85[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12351392	0.85[CHB][hapmap];1.00[JPT][hapmap];0.81[YRI][hapmap];0.89[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12380875	0.85[CHB][hapmap];1.00[JPT][hapmap];0.85[YRI][hapmap];1.00[AFR][1000 genomes];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs17231346	0.85[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1886377	0.90[AMR][1000 genomes];0.92[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2104363	1.00[JPT][hapmap];0.92[YRI][hapmap];0.95[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs2636893	0.80[JPT][hapmap]
rs2763196	0.80[JPT][hapmap]
rs2787329	0.81[JPT][hapmap]
rs28673998	0.87[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs28719625	1.00[AFR][1000 genomes];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs55833018	0.96[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs9987709	0.83[YRI][hapmap]

Variant overlapped rSNPs/rCNVs (count:34 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv430093	chr9:116330446-117325446	Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	165 gene(s)	inside rSNPs	diseases
2	esv2422396	chr9:116792944-117354862	Weak transcription Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	155 gene(s)	inside rSNPs	diseases
3	esv2422492	chr9:116811294-117366643	Genic enhancers ZNF genes & repeats Flanking Active TSS Weak transcription Strong transcription Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	155 gene(s)	inside rSNPs	diseases
4	nsv466533	chr9:116930100-117248479	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA	128 gene(s)	inside rSNPs	diseases
5	nsv615233	chr9:116930100-117248479	Genic enhancers Weak transcription Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA	128 gene(s)	inside rSNPs	diseases
6	nsv1051544	chr9:116944940-117443031	ZNF genes & repeats Genic enhancers Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
7	nsv540203	chr9:116944940-117443031	Enhancers Weak transcription Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
8	nsv1048093	chr9:116945025-117456210	Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
9	nsv1050991	chr9:116953739-117442999	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
10	nsv1046311	chr9:116953739-117447142	Genic enhancers Transcr. at gene 5' and 3' Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
11	nsv1052877	chr9:116953739-117456210	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
12	nsv1039681	chr9:116953739-117457158	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
13	nsv1051987	chr9:116955841-117453668	Flanking Active TSS Strong transcription Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
14	nsv1044374	chr9:116955841-117460150	Genic enhancers Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
15	nsv466534	chr9:116956268-117455810	Weak transcription Enhancers Active TSS Strong transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
16	nsv615234	chr9:116956268-117455810	Enhancers Strong transcription Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
17	nsv1048817	chr9:116957958-117456210	Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
18	nsv615235	chr9:116958144-117367061	ZNF genes & repeats Weak transcription Flanking Active TSS Genic enhancers Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	148 gene(s)	inside rSNPs	diseases
19	nsv615236	chr9:116958144-117455810	Strong transcription Genic enhancers Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
20	nsv466535	chr9:116958144-117456175	Enhancers Genic enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
21	nsv615237	chr9:116958144-117456175	Strong transcription Active TSS Genic enhancers Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
22	nsv615238	chr9:116958144-117458475	Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
23	nsv430094	chr9:116958446-117456446	Strong transcription Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
24	nsv1053756	chr9:116975934-117443031	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
25	nsv540204	chr9:116975934-117443031	Genic enhancers Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
26	nsv1047704	chr9:116978041-117399362	Weak transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
27	nsv540205	chr9:116978041-117399362	Enhancers Weak transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
28	nsv530950	chr9:117009156-117399361	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
29	nsv916139	chr9:117009169-117399454	Weak transcription Active TSS Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
30	nsv1047822	chr9:117010663-117211517	Flanking Active TSS Enhancers Strong transcription Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
31	nsv530951	chr9:117032675-117439804	Flanking Active TSS Weak transcription Genic enhancers Enhancers Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
32	nsv1050256	chr9:117106276-117247033	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
33	nsv540206	chr9:117106276-117247033	Flanking Active TSS Weak transcription Enhancers Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
34	nsv831693	chr9:117116450-117281895	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:118 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:117150400-117159800	Weak transcription	Psoas Muscle	Psoas
2	chr9:117150800-117159400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr9:117150800-117159400	Genic enhancers	Primary B cells from peripheral blood	blood
4	chr9:117151000-117159400	Weak transcription	HUES48 Cell Line	embryonic stem cell
5	chr9:117151000-117159400	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr9:117151000-117159400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr9:117152000-117159600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
8	chr9:117152200-117159600	Weak transcription	Placenta Amnion	Placenta Amnion
9	chr9:117153000-117159600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr9:117153000-117159600	Weak transcription	Small Intestine	intestine
11	chr9:117153200-117159600	Weak transcription	NHDF-Ad	bronchial
12	chr9:117154400-117159600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr9:117154400-117159600	Enhancers	Liver	Liver
14	chr9:117155200-117159800	Weak transcription	Left Ventricle	heart
15	chr9:117155400-117159400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr9:117155400-117159600	Enhancers	Primary T killer memory cells from peripheral blood	blood
17	chr9:117155400-117159600	Weak transcription	Fetal Kidney	kidney
18	chr9:117155400-117159600	Weak transcription	Hela-S3	cervix
19	chr9:117155600-117159400	Weak transcription	Fetal Intestine Large	intestine
20	chr9:117156000-117159600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr9:117156000-117159600	Weak transcription	NHEK	skin
22	chr9:117156400-117159400	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr9:117156400-117159800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr9:117156600-117159400	Enhancers	Primary hematopoietic stem cells	blood
25	chr9:117156600-117159400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
26	chr9:117156600-117159600	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr9:117156600-117159600	Enhancers	Brain Cingulate Gyrus	brain
28	chr9:117156600-117159800	Flanking Active TSS	Brain Germinal Matrix	brain
29	chr9:117156800-117159400	Enhancers	Brain Hippocampus Middle	brain
30	chr9:117156800-117159400	Enhancers	Fetal Muscle Leg	muscle
31	chr9:117156800-117159400	Enhancers	Stomach Mucosa	stomach
32	chr9:117156800-117159800	Enhancers	Spleen	Spleen
33	chr9:117157000-117159600	Enhancers	Brain Angular Gyrus	brain
34	chr9:117157000-117159600	Enhancers	Fetal Muscle Trunk	muscle
35	chr9:117157200-117159400	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr9:117157200-117159800	Weak transcription	HSMM	muscle
37	chr9:117157400-117159400	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr9:117157800-117159600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr9:117157800-117159600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
40	chr9:117157800-117159800	Weak transcription	Right Atrium	heart
41	chr9:117158000-117159400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
42	chr9:117158000-117159400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
43	chr9:117158000-117159400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
44	chr9:117158000-117159600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr9:117158000-117159600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr9:117158000-117159600	Weak transcription	Esophagus	oesophagus
47	chr9:117158000-117159600	Enhancers	Fetal Stomach	stomach
48	chr9:117158000-117159800	Weak transcription	Aorta	Aorta
49	chr9:117158000-117159800	Weak transcription	Fetal Heart	heart
50	chr9:117158000-117159800	Weak transcription	Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links